Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
Penn study shows potential of interferon pathway as biomarker, therapeutic target
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Read moreAnalysis of the Evolution of CAR T-cell Immunotherapy through Patenting Activity
Nature Biotechnology review of emerging technology of chimeric antigen receptor (CAR) T-cell immunotherapy shows six of the top 20 global CAR-T inventors are from Penn.
Read morePenn's Gene Therapy Startup Raises Another $50 Million
Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.
Read moreNational Blood Foundation Early-Career Grant for Dr. Vijay Bhoj
Award for research in the fields of transfusion medicine and cellular therapies.
Read moreChimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Global CAR T Therapy Trial Shows High Rates of Durable Remission for Non-Hodgkin’s Lymphoma: Additional data shows remissions past two years among patients treated in earlier pilot study.
Read more